The effectiveness of telemedicine in the prevention of type 2 diabetes mellitus : a systematic review and meta-analysis of interventions
(2025) In Diabetes and Metabolic Syndrome: Clinical Research and Reviews 19(5).- Abstract
Objective: To evaluate the effectiveness of telemedicine-delivered diet and/or exercise interventions to prevent type 2 diabetes (T2D) in people at risk. Methods: Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010–December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analysed, and other intervention designs narratively synthesized. Results: We identified 11,645 studies via database searches, of which 226 were full-text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis.... (More)
Objective: To evaluate the effectiveness of telemedicine-delivered diet and/or exercise interventions to prevent type 2 diabetes (T2D) in people at risk. Methods: Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010–December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analysed, and other intervention designs narratively synthesized. Results: We identified 11,645 studies via database searches, of which 226 were full-text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis. Telemedicine interventions reduced body weight (mean difference (MD): −1.66 kg, 95 % confidence interval (CI) −2.48,-0.90, I2 = 81 %, nstudies = 17), body mass index (MD -0.71 kg/m2, 95 % CI -1.06,-0.37, I2 = 70 %, nstudies = 11), waist circumference (MD -2.82 cm, 95 % CI -5.16,-2.35, I2 = 84 %, nstudies = 8) and HbA1c (MD -0.07 %, 95 % CI -0.14,0.00, I2 = 71 %, nstudies = 11). No significant effects were found for other clinical outcomes. The narrative synthesis supported the results. The longest follow-up time was up to 24 months. Conclusions: Our study demonstrates effectiveness for telemedicine-delivered interventions in preventing T2D in people at risk, specifically in people with overweight/obesity.
(Less)
- author
- Suhlrie, Laura
; Ayyagari, Raga
; Mba, Camille
; Olsson, Kjell
LU
; Torres-Aparcana, Harold
; James, Steven
; Vounzoulaki, Elpida
and Ibsen, Daniel B.
- organization
- publishing date
- 2025-05
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Diabetes and Metabolic Syndrome: Clinical Research and Reviews
- volume
- 19
- issue
- 5
- article number
- 103252
- publisher
- Diabetes India
- external identifiers
-
- pmid:40527161
- scopus:105008191169
- ISSN
- 1871-4021
- DOI
- 10.1016/j.dsx.2025.103252
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © 2025 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC)
- id
- 99c36ef1-e199-4a65-8f5a-4224721d131d
- date added to LUP
- 2025-12-18 14:29:22
- date last changed
- 2025-12-19 03:01:57
@article{99c36ef1-e199-4a65-8f5a-4224721d131d,
abstract = {{<p>Objective: To evaluate the effectiveness of telemedicine-delivered diet and/or exercise interventions to prevent type 2 diabetes (T2D) in people at risk. Methods: Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010–December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analysed, and other intervention designs narratively synthesized. Results: We identified 11,645 studies via database searches, of which 226 were full-text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis. Telemedicine interventions reduced body weight (mean difference (MD): −1.66 kg, 95 % confidence interval (CI) −2.48,-0.90, I<sup>2</sup> = 81 %, n<sub>studies</sub> = 17), body mass index (MD -0.71 kg/m<sup>2</sup>, 95 % CI -1.06,-0.37, I<sup>2</sup> = 70 %, n<sub>studies</sub> = 11), waist circumference (MD -2.82 cm, 95 % CI -5.16,-2.35, I<sup>2</sup> = 84 %, n<sub>studies</sub> = 8) and HbA1c (MD -0.07 %, 95 % CI -0.14,0.00, I<sup>2</sup> = 71 %, n<sub>studies</sub> = 11). No significant effects were found for other clinical outcomes. The narrative synthesis supported the results. The longest follow-up time was up to 24 months. Conclusions: Our study demonstrates effectiveness for telemedicine-delivered interventions in preventing T2D in people at risk, specifically in people with overweight/obesity.</p>}},
author = {{Suhlrie, Laura and Ayyagari, Raga and Mba, Camille and Olsson, Kjell and Torres-Aparcana, Harold and James, Steven and Vounzoulaki, Elpida and Ibsen, Daniel B.}},
issn = {{1871-4021}},
language = {{eng}},
number = {{5}},
publisher = {{Diabetes India}},
series = {{Diabetes and Metabolic Syndrome: Clinical Research and Reviews}},
title = {{The effectiveness of telemedicine in the prevention of type 2 diabetes mellitus : a systematic review and meta-analysis of interventions}},
url = {{http://dx.doi.org/10.1016/j.dsx.2025.103252}},
doi = {{10.1016/j.dsx.2025.103252}},
volume = {{19}},
year = {{2025}},
}